Business
Helix BioPharma Corp. Extends Date of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing
(TheNewswire) February 2 4 , 2025 - (Toronto, Ontario) – TheNewswire – ...
About this update from Helix Biopharma Corp.
[{"type":"text","content":"Helix BioPharma Corp. Extends Date of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n February 2\n \n 4\n \n , 2025 - (Toronto, Ontario) –\n \n TheNewswire –\n \n Helix BioPharma Corp. (TSX: “HBP”,\nOTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix” or the\n“Company”), a clinical-stage oncology company shaping a near\nfuture where today’s hard-to-treat cancers are vincible, announces\nthat its Annual General and Special Meeting (the “Meeting”) for\nthe year ended July 31, 2024, that was to be held by January 31, 2025,\nhas been extended to March 26, 2025 to provide additional time to seek\nshareholder approval with respect to its proposed asset acquisitions\nfrom Laevoroc Immunology AG and Laevoroc Chemotherapy AG (the “Asset\nAcquisitions”), as well as a proposed financing utilizing a\ndraw-down subscription facility structure.\n \n\n The Company has applied to the Ontario Superior Court of Justice for\nan order under section 133(3) of the Canada Business Corporations Act\npermitting it to hold the Meeting by March 26, 2025. The application\nis scheduled to be heard on Wednesday, February 26, 2025, at 10:00 am,\nby videoconference. Any interested party may attend the hearing, and,\nif the court permits, make submissions.\n \n\n The Company received an acknowledgement from the Toronto Stock\nExchange to hold the Meeting on or before March 26, 2025. The Company\nexpects to hold a further annual general meeting before January 31,\n2026 as is required under applicable corporate and securities laws.\n \n\n For more information on the Asset Acquisitions, please see the\nCompany’s news releases dated November 29, 2024, December 2, 2024,\nDecember 6, 2024.\n \n\n The Notice of Meeting, Management Information Circular, Financial\nStatements Request Form, Form of Proxy and Voting Instruction Form\n(the “Meeting Materials”) will be mailed to shareholders and\nposted on the Company’s profile on SEDAR+ at www.sedarplus.ca on or\nbefore February 24, 2025.\n \n\n Shareholders of record as of January 31, 2025, are entitled to vote\ntheir shares of the Company at the Meeting. The Company encourages its\n...